BioCentury
ARTICLE | Financial News

Imagion proposes A$12M Australian IPO

June 9, 2017 3:17 AM UTC

On May 3, nanobiotechnology company Imagion Biosystems Ltd. (Melbourne, Australia) propose to raise up to A$12 million ($9 million) in an IPO on the ASX Ltd. through the sale of 60 million shares at A$0.20. Focus Capital Partners is the lead manager for the offering...